 <h1>Pavulon Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>pancuronium</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about pancuronium. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Pavulon.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to pancuronium: parenteral injection</i></p><h3>Warning</h3><p><ul>
<li>
Should be administered only by adequately trained clinicians experienced in the use and complications of neuromuscular blocking agents.&lt;sup&gt;100&lt;/sup&gt;</li></ul></p><ul>
<li>
Should be administered only by adequately trained clinicians experienced in the use and complications of neuromuscular blocking agents.&lt;sup&gt;100&lt;/sup&gt;</li></ul><p></p><p>Side effects include:</p><p>Various degrees of skeletal muscle weakness. </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to pancuronium: intravenous solution</i></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Severe anaphylactic reactions<sup>[Ref]</sup></p><h3>Local</h3><p><b>Uncommon</b> (0.1% to 1%): Pain and burning at injection site<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Prolonged paralysis, disuse atrophy, and areflexia have been reported with prolonged use of this drug<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Decreased intraocular pressure, miosis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Rare</b> (less than 0.1%): Bronchospasm, wheezing </p><p><b>Frequency not reported</b>: Apnea, respiratory depression<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Mild to moderate increase in blood pressure and/or pulse rate (10%)</p><p><b>Rare</b> (less than 0.1%): Hypotension, cardiovascular collapse, flushing, edema, arrhythmia, bradycardia</p><p><b>Frequency not reported</b>: Dysrhythmias, increased cardiac output<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Transient rash, pruritus, redness<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Frequency not reported</b>: Hypersalivation<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Pancuronium Bromide (pancuronium)." Hospira Inc, Lake Forest, IL. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about Pavulon (pancuronium)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: neuromuscular blocking agents</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>